Exact Mass: 488.0703

Exact Mass Matches: 488.0703

Found 84 metabolites which its exact mass value is equals to given mass value 488.0703, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Citicoline

2-(((((((2R,3S,4R,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)oxy)oxidophosphoryl)oxy)-N,N,N-trimethylethanaminium

C14H26N4O11P2 (488.1073)


CDP-choline is a member of the class of phosphocholines that is the chloine ester of CDP. It is an intermediate obtained in the biosynthetic pathway of structural phospholipids in cell membranes. It has a role as a human metabolite, a psychotropic drug, a neuroprotective agent, a Saccharomyces cerevisiae metabolite and a mouse metabolite. It is a member of phosphocholines and a member of nucleotide-(amino alcohol)s. It is functionally related to a CDP. It is a conjugate base of a CDP-choline(1+). Citicoline is a donor of choline in biosynthesis of choline-containing phosphoglycerides. It has been investigated for the treatment, supportive care, and diagnosis of Mania, Stroke, Hypomania, Cocaine Abuse, and Bipolar Disorder, among others. Citicoline is a nutritional supplement and source of choline and cytidine with potential neuroprotective and nootropic activity. Citicoline, also known as cytidine-5-diphosphocholine or CDP-choline, is hydrolyzed into cytidine and choline in the intestine. Following absorption, both cytidine and choline are dispersed, utilized in various biosynthesis pathways, and cross the blood-brain barrier for resynthesis into citicoline in the brain, which is the rate-limiting product in the synthesis of phosphatidylcholine. This agent also increases acetylcholine (Ach), norepinephrine (NE) and dopamine levels in the central nervous system (CNS). In addition, citicoline is involved in the preservation of sphingomyelin and cardiolipin and the restoration of Na+/K+-ATPase activity. Citicoline also increases glutathione synthesis and glutathione reductase activity, and exerts antiapoptotic effects. Donor of choline in biosynthesis of choline-containing phosphoglycerides. N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics Acquisition and generation of the data is financially supported in part by CREST/JST. D002491 - Central Nervous System Agents > D018697 - Nootropic Agents Citicoline (Cytidine diphosphate-choline) is an intermediate in the synthesis of phosphatidylcholine, a component of cell membranes. Citicoline exerts neuroprotective effects. Citicoline (Cytidine diphosphate-choline) is an intermediate in the synthesis of phosphatidylcholine, a component of cell membranes. Citicoline exerts neuroprotective effects.

   

Flufenoxuron

[({4-[2-chloro-4-(trifluoromethyl)phenoxy]-2-fluorophenyl}-C-hydroxycarbonimidoyl)imino](2,6-difluorophenyl)methanol

C21H11ClF6N2O3 (488.0362)


CONFIDENCE standard compound; INTERNAL_ID 2334 CONFIDENCE standard compound; INTERNAL_ID 8487

   
   

2,3-dihydroxypropyl [3-phosphonooxy-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl] hydrogen phosphate

2,3-dihydroxypropyl [3-phosphonooxy-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl] hydrogen phosphate

C12H26O16P2 (488.0696)


   

Tonapofylline

6-[amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl]-4-(3-chlorophenyl)-1-methyl-1,2-dihydroquinolin-2-one

C27H22Cl2N4O (488.1171)


   

Cytidine-5'-diphosphocholine

{2-[({[5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl phosphono)oxy]ethyl}trimethylazanium

C14H26N4O11P2 (488.1073)


D002491 - Central Nervous System Agents > D018697 - Nootropic Agents

   

Iron(III) ammonium citrate

Iron(3+) ion 2-hydroxypropane-1,2,3-tricarboxylic acid 2-hydroxypropane-1,2,3-tricarboxylic acid triamine

C12H22FeN3O14 (488.0451)


Anticaking agent, dietary iron supplement. May be used in infant formulas [DFC]. A complex salt of undetermined structure, composed of iron, ammonia and citric acid; there are two types of salts - brown and green - containing different amounts of iron. [JECFA] Anticaking agent, dietary iron supplement. May be used in infant formulas [DFC]

   

Protocercosporin

Protocercosporin

C27H20O9 (488.1107)


   
   

Xanthoviridicatin E

Xanthoviridicatin E

C27H20O9 (488.1107)


   
   
   

SCHEMBL14286440

SCHEMBL14286440

C26H16O10 (488.0743)


   

squarrosidine

squarrosidine

C27H20O9 (488.1107)


   

SCHEMBL7627853

SCHEMBL7627853

C23H20O12 (488.0955)


   

rostratin D

rostratin D

C18H20N2O6S4 (488.0204)


An organic disulfide isolated from the whole broth of the marine-derived fungus Exserohilum rostratum and has been shown to exhibit antineoplastic activity.

   

12-O-beta-D-glucopyranosyl-2,3,7,11-tetrahydroxy-6-oxabenzo[a]anthracen-5-one|2,3,7,11-tetrahydroxy-5-oxo-5H-dibenzo[c,g]chromen-12-yl beta-D-glucopyranoside|juglanthracenoside A

12-O-beta-D-glucopyranosyl-2,3,7,11-tetrahydroxy-6-oxabenzo[a]anthracen-5-one|2,3,7,11-tetrahydroxy-5-oxo-5H-dibenzo[c,g]chromen-12-yl beta-D-glucopyranoside|juglanthracenoside A

C23H20O12 (488.0955)


   

SCHEMBL7870113

SCHEMBL7870113

C23H20O12 (488.0955)


   

1,8,9,10-tetrahydroxy-6H-naphtho[1,2-b]benzo[d]pyran-6-one-12-O-beta-D-glucopyranoside|jugnaphthalenoside A

1,8,9,10-tetrahydroxy-6H-naphtho[1,2-b]benzo[d]pyran-6-one-12-O-beta-D-glucopyranoside|jugnaphthalenoside A

C23H20O12 (488.0955)


   

4-hydroxytetracenomycin C 4

4-hydroxytetracenomycin C 4

C23H20O12 (488.0955)


   

NESS 0327

8-chloro-1-(2,4-dichlorophenyl)-1,4,5,6-tetrahydro-N-1-piperidinyl-benzo[6,7]cyclohepta[1,2-c]pyrazole-3-carboxamide

C24H23Cl3N4O (488.0937)


   

cytidine 5-diphosphocholine

cytidine 5-diphosphocholine

C14H26N4O11P2 (488.1073)


   

Suncholin

Cytidine-5-diphosphocholine sodium salt dihydrate, from yeast, solid

C14H26N4O11P2 (488.1073)


Citicoline (Cytidine diphosphate-choline) is an intermediate in the synthesis of phosphatidylcholine, a component of cell membranes. Citicoline exerts neuroprotective effects. Citicoline (Cytidine diphosphate-choline) is an intermediate in the synthesis of phosphatidylcholine, a component of cell membranes. Citicoline exerts neuroprotective effects.

   

Citicoline

2-(((((((2R,3S,4R,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)oxy)oxidophosphoryl)oxy)-N,N,N-trimethylethanaminium

C14H26N4O11P2 (488.1073)


CDP-choline is a member of the class of phosphocholines that is the chloine ester of CDP. It is an intermediate obtained in the biosynthetic pathway of structural phospholipids in cell membranes. It has a role as a human metabolite, a psychotropic drug, a neuroprotective agent, a Saccharomyces cerevisiae metabolite and a mouse metabolite. It is a member of phosphocholines and a member of nucleotide-(amino alcohol)s. It is functionally related to a CDP. It is a conjugate base of a CDP-choline(1+). Citicoline is a donor of choline in biosynthesis of choline-containing phosphoglycerides. It has been investigated for the treatment, supportive care, and diagnosis of Mania, Stroke, Hypomania, Cocaine Abuse, and Bipolar Disorder, among others. Citicoline is a nutritional supplement and source of choline and cytidine with potential neuroprotective and nootropic activity. Citicoline, also known as cytidine-5-diphosphocholine or CDP-choline, is hydrolyzed into cytidine and choline in the intestine. Following absorption, both cytidine and choline are dispersed, utilized in various biosynthesis pathways, and cross the blood-brain barrier for resynthesis into citicoline in the brain, which is the rate-limiting product in the synthesis of phosphatidylcholine. This agent also increases acetylcholine (Ach), norepinephrine (NE) and dopamine levels in the central nervous system (CNS). In addition, citicoline is involved in the preservation of sphingomyelin and cardiolipin and the restoration of Na+/K+-ATPase activity. Citicoline also increases glutathione synthesis and glutathione reductase activity, and exerts antiapoptotic effects. Donor of choline in biosynthesis of choline-containing phosphoglycerides. N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics D002491 - Central Nervous System Agents > D018697 - Nootropic Agents Citicoline (Cytidine diphosphate-choline) is an intermediate in the synthesis of phosphatidylcholine, a component of cell membranes. Citicoline exerts neuroprotective effects. Citicoline (Cytidine diphosphate-choline) is an intermediate in the synthesis of phosphatidylcholine, a component of cell membranes. Citicoline exerts neuroprotective effects.

   

Nicholin

cytidine 5-diphosphocholine

C14H26N4O11P2 (488.1073)


N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics D002491 - Central Nervous System Agents > D018697 - Nootropic Agents Citicoline (Cytidine diphosphate-choline) is an intermediate in the synthesis of phosphatidylcholine, a component of cell membranes. Citicoline exerts neuroprotective effects. Citicoline (Cytidine diphosphate-choline) is an intermediate in the synthesis of phosphatidylcholine, a component of cell membranes. Citicoline exerts neuroprotective effects.

   

Recofnan

Cytidine-5-diphosphocholine sodium salt dihydrate, from yeast, solid

C14H26N4O11P2 (488.1073)


Citicoline (Cytidine diphosphate-choline) is an intermediate in the synthesis of phosphatidylcholine, a component of cell membranes. Citicoline exerts neuroprotective effects. Citicoline (Cytidine diphosphate-choline) is an intermediate in the synthesis of phosphatidylcholine, a component of cell membranes. Citicoline exerts neuroprotective effects.

   

Flufenoxuron

Pesticide3_Flufenoxuron_C21H11ClF6N2O3_N-({4-[2-Chloro-4-(trifluoromethyl)phenoxy]-2-fluorophenyl}carbamoyl)-2,6-difluorobenzamide

C21H11ClF6N2O3 (488.0362)


   

CYTIDINE 5'-DIPHOSPHOCHOLINE

CYTIDINE 5'-DIPHOSPHOCHOLINE

C14H26N4O11P2 (488.1073)


   

CDP-Choline; LC-tDDA; CE10

CDP-Choline; LC-tDDA; CE10

C14H26N4O11P2 (488.1073)


   

CDP-Choline; LC-tDDA; CE20

CDP-Choline; LC-tDDA; CE20

C14H26N4O11P2 (488.1073)


   

CDP-Choline; LC-tDDA; CE30

CDP-Choline; LC-tDDA; CE30

C14H26N4O11P2 (488.1073)


   

CDP-Choline; LC-tDDA; CE40

CDP-Choline; LC-tDDA; CE40

C14H26N4O11P2 (488.1073)


   

Phe4Cl-Phe4Cl-OH

(S)-2-(3-((4-chlorobenzyl)oxy)-4-nitrobenzamido)-3-(4-chlorophenyl)propanoic acid

C23H18Cl2N2O6 (488.0542)


   

sodium m-[[[4-(benzothiazol-2-ylazo)-m-tolyl]ethylamino]methyl]benzenesulphonate

sodium m-[[[4-(benzothiazol-2-ylazo)-m-tolyl]ethylamino]methyl]benzenesulphonate

C23H21N4NaO3S2 (488.0953)


   

Tiametonium iodide

Tiametonium iodide

C12H30I2N2S (488.0219)


   

P-DIANISAL-3,3-DICHLOROBENZIDINE

P-DIANISAL-3,3-DICHLOROBENZIDINE

C28H22Cl2N2O2 (488.1058)


   

3 4 5 6-TETRAFLUOROFLUORESCEIN DIACETAT&

3 4 5 6-TETRAFLUOROFLUORESCEIN DIACETAT&

C24H12F4O7 (488.0519)


   

3,3-Dipropyloxacarbocyanine iodide

3,3-Dipropyloxacarbocyanine iodide

C23H25IN2O2 (488.0961)


   

N-[6-(6-Chloro-5-{[(4-methoxyphenyl)sulfonyl]amino}-3-pyridinyl)- 1,3-benzothiazol-2-yl]acetamide

N-[6-(6-Chloro-5-{[(4-methoxyphenyl)sulfonyl]amino}-3-pyridinyl)- 1,3-benzothiazol-2-yl]acetamide

C21H17ClN4O4S2 (488.038)


   

Tipifarnib

Tipifarnib

C27H22Cl2N4O (488.1171)


C471 - Enzyme Inhibitor > C2020 - Farnesyl Transferase Inhibitor D000970 - Antineoplastic Agents

   

PENTAERYTHRITOL TETRA(3-MERCAPTOPROPIONATE)

PENTAERYTHRITOL TETRA(3-MERCAPTOPROPIONATE)

C17H28O8S4 (488.0667)


   

(ACETYLCYCLOPENTADIENYL)CYCLOPENTADIENYLIRON

(ACETYLCYCLOPENTADIENYL)CYCLOPENTADIENYLIRON

C23H22IO2P (488.0402)


   

dihydroxydibenzanthrone

dihydroxydibenzanthrone

C34H16O4 (488.1049)


   

3-(1h,1h,9h-hexadecafluorononyloxy)-1,2-epoxypropane

3-(1h,1h,9h-hexadecafluorononyloxy)-1,2-epoxypropane

C12H8F16O2 (488.0269)


   

3-(6-(1-(2,2-DIFLUOROBENZO[D][1,3]DIOXOL-5-YL)CYCLOPROPANECARBOXAMIDO)-3-METHYLPYRIDIN-2-YL)BENZOIC ACID HYDROCHLORIDE

3-(6-(1-(2,2-DIFLUOROBENZO[D][1,3]DIOXOL-5-YL)CYCLOPROPANECARBOXAMIDO)-3-METHYLPYRIDIN-2-YL)BENZOIC ACID HYDROCHLORIDE

C24H19ClF2N2O5 (488.095)


   

2(1H)-Quinolinone, 6-(amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl)-4-(3-chlorophenyl)-1-methyl-

2(1H)-Quinolinone, 6-(amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl)-4-(3-chlorophenyl)-1-methyl-

C27H22Cl2N4O (488.1171)


D000970 - Antineoplastic Agents

   

Tipifarnib S enantiomer

Tipifarnib S enantiomer

C27H22Cl2N4O (488.1171)


   

2-[1-(4-bromophenoxy)butyl]-8,9-dimethoxy-3H-[1,2,4]triazolo[1,5-c]quinazoline-5-thione

2-[1-(4-bromophenoxy)butyl]-8,9-dimethoxy-3H-[1,2,4]triazolo[1,5-c]quinazoline-5-thione

C21H21BrN4O3S (488.0518)


   

1-(2,6-Dichlorophenyl)-5-(2,4-difluorophenyl)-7-piperazin-1-YL-3,4-dihydroquinazolin-2(1H)-one

1-(2,6-Dichlorophenyl)-5-(2,4-difluorophenyl)-7-piperazin-1-YL-3,4-dihydroquinazolin-2(1H)-one

C24H20Cl2F2N4O (488.0982)


   

5-(5-Chloro-2-Thienyl)-N-{(3s)-1-[(1s)-1-Methyl-2-Morpholin-4-Yl-2-Oxoethyl]-2-Oxopyrrolidin-3-Yl}-1h-1,2,4-Triazole-3-Sulfonamide

5-(5-Chloro-2-Thienyl)-N-{(3s)-1-[(1s)-1-Methyl-2-Morpholin-4-Yl-2-Oxoethyl]-2-Oxopyrrolidin-3-Yl}-1h-1,2,4-Triazole-3-Sulfonamide

C17H21ClN6O5S2 (488.0703)


   

3-[4,5-dihydroxy-2-[(E)-2-(4-hydroxy-6-oxopyran-2-yl)ethenyl]phenyl]-6-[(E)-2-(3-hydroxy-4-oxidophenyl)ethenyl]-2-oxopyran-4-olate

3-[4,5-dihydroxy-2-[(E)-2-(4-hydroxy-6-oxopyran-2-yl)ethenyl]phenyl]-6-[(E)-2-(3-hydroxy-4-oxidophenyl)ethenyl]-2-oxopyran-4-olate

C26H16O10-2 (488.0743)


   

N-[4-[(2,6-difluorophenyl)sulfonylamino]cyclohexyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide

N-[4-[(2,6-difluorophenyl)sulfonylamino]cyclohexyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide

C20H22F2N2O6S2 (488.0887)


   

N-(2-hydroxyethyl)-5-methyl-N-[(7-oxo-3,6-dihydro-2H-[1,4]dioxino[2,3-g]quinolin-8-yl)methyl]-2,1,3-benzothiadiazole-4-sulfonamide

N-(2-hydroxyethyl)-5-methyl-N-[(7-oxo-3,6-dihydro-2H-[1,4]dioxino[2,3-g]quinolin-8-yl)methyl]-2,1,3-benzothiadiazole-4-sulfonamide

C21H20N4O6S2 (488.0824)


   

[4-[(E)-[[2-(4-chlorophenoxy)acetyl]hydrazinylidene]methyl]-2-ethoxyphenyl] benzenesulfonate

[4-[(E)-[[2-(4-chlorophenoxy)acetyl]hydrazinylidene]methyl]-2-ethoxyphenyl] benzenesulfonate

C23H21ClN2O6S (488.0809)


   
   

ethyl (2E)-2-[(4-hydroxyphenyl)methylidene]-3-oxo-7-phenyl-5-thiophen-2-yl-5H-[1,3]thiazolo[3,2-a]pyrimidine-6-carboxylate

ethyl (2E)-2-[(4-hydroxyphenyl)methylidene]-3-oxo-7-phenyl-5-thiophen-2-yl-5H-[1,3]thiazolo[3,2-a]pyrimidine-6-carboxylate

C26H20N2O4S2 (488.0864)


   

3-Dehydrocarminate

3-Dehydrocarminate

C22H16O13-2 (488.0591)


   

(3E)-2-(4-Chloroanilino)-5-(4-chlorophenyl)-3-isopropylimino-phenazin-1-OL

(3E)-2-(4-Chloroanilino)-5-(4-chlorophenyl)-3-isopropylimino-phenazin-1-OL

C27H22Cl2N4O (488.1171)


   

8-(6-Carboxy-2,3,4-trihydroxyphenoxy)-3,4,9,10-tetrahydroxy-6-oxobenzo[c]chromene-1-carboxylic acid

8-(6-Carboxy-2,3,4-trihydroxyphenoxy)-3,4,9,10-tetrahydroxy-6-oxobenzo[c]chromene-1-carboxylic acid

C21H12O14 (488.0227)


   

5-(3-Bromo-4-hydroxy-5-methoxyphenyl)-4-(5-methylfuran-2-carbonyl)-1-(5-methyl-1,2-oxazol-3-yl)pyrrolidine-2,3-dione

5-(3-Bromo-4-hydroxy-5-methoxyphenyl)-4-(5-methylfuran-2-carbonyl)-1-(5-methyl-1,2-oxazol-3-yl)pyrrolidine-2,3-dione

C21H17BrN2O7 (488.0219)


   

ethyl 5-acetyl-2-[[2-[(8-fluoro-5H-[1,2,4]triazino[5,6-b]indol-4-ium-3-yl)sulfanyl]acetyl]amino]-4-methylthiophene-3-carboxylate

ethyl 5-acetyl-2-[[2-[(8-fluoro-5H-[1,2,4]triazino[5,6-b]indol-4-ium-3-yl)sulfanyl]acetyl]amino]-4-methylthiophene-3-carboxylate

C21H19FN5O4S2+ (488.0862)


   

6-[(S)-amino-(4-chlorophenyl)-(3-methyl-4-imidazolyl)methyl]-4-(3-chlorophenyl)-1-methyl-2-quinolinone

6-[(S)-amino-(4-chlorophenyl)-(3-methyl-4-imidazolyl)methyl]-4-(3-chlorophenyl)-1-methyl-2-quinolinone

C27H22Cl2N4O (488.1171)


   

CDP-choline

CDP-choline

C14H26N4O11P2 (488.1073)


A member of the class of phosphocholines that is the chloine ester of CDP. It is an intermediate obtained in the biosynthetic pathway of structural phospholipids in cell membranes.

   
   

methyl 4-[(2r,5s)-5-[(3e)-12,12-dibromododeca-3,11-dien-1-yn-1-yl]oxolan-2-yl]butanoate

methyl 4-[(2r,5s)-5-[(3e)-12,12-dibromododeca-3,11-dien-1-yn-1-yl]oxolan-2-yl]butanoate

C21H30Br2O3 (488.0562)


   
   

3-{9,10-dihydroxy-7-methoxy-3-methyl-1-oxobenzo[g]isochromen-8-yl}-5-hydroxy-2-methoxy-7-methylnaphthalene-1,4-dione

3-{9,10-dihydroxy-7-methoxy-3-methyl-1-oxobenzo[g]isochromen-8-yl}-5-hydroxy-2-methoxy-7-methylnaphthalene-1,4-dione

C27H20O9 (488.1107)


   

7,10,15,16-tetrahydroxy-8-methoxy-3-methyl-3,4,6,7-tetrahydro-2-oxahexaphene-1,9,14-trione

7,10,15,16-tetrahydroxy-8-methoxy-3-methyl-3,4,6,7-tetrahydro-2-oxahexaphene-1,9,14-trione

C27H20O9 (488.1107)


   

2-{[3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-3-{[3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}butanedioic acid

2-{[3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-3-{[3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}butanedioic acid

C23H20O12 (488.0955)


   

{2-[({[(2s,3s,4r,5s)-3,4-dihydroxy-5-(2-hydroxy-4-iminopyrimidin-1-yl)oxolan-2-yl]methyl phosphonato}oxy(hydroxy)phosphoryl)oxy]ethyl}trimethylazanium

{2-[({[(2s,3s,4r,5s)-3,4-dihydroxy-5-(2-hydroxy-4-iminopyrimidin-1-yl)oxolan-2-yl]methyl phosphonato}oxy(hydroxy)phosphoryl)oxy]ethyl}trimethylazanium

C14H26N4O11P2 (488.1073)


   

3-({6-[2-(3,4-dihydroxyphenyl)ethenyl]-4-hydroxy-2-oxopyran-3-yl}methyl)-4-hydroxy-6-[2-(4-hydroxyphenyl)ethenyl]pyran-2-one

3-({6-[2-(3,4-dihydroxyphenyl)ethenyl]-4-hydroxy-2-oxopyran-3-yl}methyl)-4-hydroxy-6-[2-(4-hydroxyphenyl)ethenyl]pyran-2-one

C27H20O9 (488.1107)


   

(1r,4s,5r,6r,9s,11r,14s,15r,16r,19s)-5,15-dihydroxy-6,16-disulfanyl-21,22-dithia-3,13-diazahexacyclo[9.9.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁴,¹⁹]docosane-2,8,12,18-tetrone

(1r,4s,5r,6r,9s,11r,14s,15r,16r,19s)-5,15-dihydroxy-6,16-disulfanyl-21,22-dithia-3,13-diazahexacyclo[9.9.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁴,¹⁹]docosane-2,8,12,18-tetrone

C18H20N2O6S4 (488.0204)


   

(1s,14r,24s)-5,7,19,24-tetrahydroxy-11,17-dimethyl-6,22-dioxaheptacyclo[12.9.1.1¹,¹⁶.1⁴,⁸.0²,¹³.0¹²,²⁶.0²⁰,²⁵]hexacosa-2(13),4,7,10,12(26),16(25),17,19-octaene-3,9,15,21-tetrone

(1s,14r,24s)-5,7,19,24-tetrahydroxy-11,17-dimethyl-6,22-dioxaheptacyclo[12.9.1.1¹,¹⁶.1⁴,⁸.0²,¹³.0¹²,²⁶.0²⁰,²⁵]hexacosa-2(13),4,7,10,12(26),16(25),17,19-octaene-3,9,15,21-tetrone

C26H16O10 (488.0743)


   

5,15-dihydroxy-6,16-disulfanyl-21,22-dithia-3,13-diazahexacyclo[9.9.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁴,¹⁹]docosane-2,8,12,18-tetrone

5,15-dihydroxy-6,16-disulfanyl-21,22-dithia-3,13-diazahexacyclo[9.9.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁴,¹⁹]docosane-2,8,12,18-tetrone

C18H20N2O6S4 (488.0204)


   

methyl 5,6a,7,10a,12-pentahydroxy-3,8-dimethoxy-1-methyl-6,10,11-trioxo-7h-tetracene-2-carboxylate

methyl 5,6a,7,10a,12-pentahydroxy-3,8-dimethoxy-1-methyl-6,10,11-trioxo-7h-tetracene-2-carboxylate

C23H20O12 (488.0955)


   

(7r)-7,10,15,16-tetrahydroxy-8-methoxy-3-methyl-3,4,6,7-tetrahydro-2-oxahexaphene-1,9,14-trione

(7r)-7,10,15,16-tetrahydroxy-8-methoxy-3-methyl-3,4,6,7-tetrahydro-2-oxahexaphene-1,9,14-trione

C27H20O9 (488.1107)


   

3-({6-[(1e)-2-(3,4-dihydroxyphenyl)ethenyl]-4-hydroxy-2-oxopyran-3-yl}methyl)-4-hydroxy-6-[(1e)-2-(4-hydroxyphenyl)ethenyl]pyran-2-one

3-({6-[(1e)-2-(3,4-dihydroxyphenyl)ethenyl]-4-hydroxy-2-oxopyran-3-yl}methyl)-4-hydroxy-6-[(1e)-2-(4-hydroxyphenyl)ethenyl]pyran-2-one

C27H20O9 (488.1107)


   

2,3,7,11-tetrahydroxy-12-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-oxatetraphen-5-one

2,3,7,11-tetrahydroxy-12-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-oxatetraphen-5-one

C23H20O12 (488.0955)


   

methyl (6ar,7s,10ar)-5,6a,7,10a,12-pentahydroxy-3,8-dimethoxy-1-methyl-6,10,11-trioxo-7h-tetracene-2-carboxylate

methyl (6ar,7s,10ar)-5,6a,7,10a,12-pentahydroxy-3,8-dimethoxy-1-methyl-6,10,11-trioxo-7h-tetracene-2-carboxylate

C23H20O12 (488.0955)


   

methyl 4-[5-(12,12-dibromododeca-3,11-dien-1-yn-1-yl)oxolan-2-yl]butanoate

methyl 4-[5-(12,12-dibromododeca-3,11-dien-1-yn-1-yl)oxolan-2-yl]butanoate

C21H30Br2O3 (488.0562)


   

(2r,3s)-2-{[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-3-{[(2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}butanedioic acid

(2r,3s)-2-{[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-3-{[(2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}butanedioic acid

C23H20O12 (488.0955)


   

(2r,3r)-2-{[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-3-{[(2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}butanedioic acid

(2r,3r)-2-{[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-3-{[(2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}butanedioic acid

C23H20O12 (488.0955)


   

2-[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]-2,3-dihydroxy-3-[(2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]butanedioic acid

2-[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]-2,3-dihydroxy-3-[(2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]butanedioic acid

C23H20O12 (488.0955)


   

3,10,15,16-tetrahydroxy-8-methoxy-3-methyl-6,7-dihydro-4h-2-oxahexaphene-1,9,14-trione

3,10,15,16-tetrahydroxy-8-methoxy-3-methyl-6,7-dihydro-4h-2-oxahexaphene-1,9,14-trione

C27H20O9 (488.1107)